Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Puglisi

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Journal of Cancer Policy|July 28, 2021
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of ItalyR Tarricone, E Listorti, V Tozzi, et al.
Breast (Edinburgh, Scotland)|September 6, 2024
Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022A De Luca, M I Amabile, F Santori, et al.
Breast Cancer Research and Treatment|April 5, 2017
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trialsM V Dieci, A Frassoldati, D Generali, et al.
Breast Cancer Research and Treatment|March 15, 2017
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trialsM V Dieci, A Frassoldati, D Generali, et al.
Breast (Edinburgh, Scotland)|June 27, 2025
Corrigendum to "Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022" [The Breast 78 (2024) 103790]A De Luca, M I Amabile, F Santori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytomaF Silvestri, G Barillari, R Fanin, et al.
Breast Cancer Research and Treatment|November 7, 2012
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozoleG Lunardi, P Piccioli, P Bruzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 16, 2023
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)P Di Nardo, D Basile, A Siciliano, et al.
European Review for Medical and Pharmacological Sciences|March 28, 2019
Biological properties of Cakile maritima Scop. (Brassicaceae) extractsV Fuochi, I Barbagallo, A Distefano, et al.
ESMO Open|January 7, 2026
Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trialsR Borea, E Blondeaux, L Carmisciano, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Journal of Cancer Policy|July 28, 2021
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of ItalyR Tarricone, E Listorti, V Tozzi, et al.
Breast (Edinburgh, Scotland)|September 6, 2024
Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022A De Luca, M I Amabile, F Santori, et al.
Breast Cancer Research and Treatment|April 5, 2017
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trialsM V Dieci, A Frassoldati, D Generali, et al.
Breast Cancer Research and Treatment|March 15, 2017
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trialsM V Dieci, A Frassoldati, D Generali, et al.
Breast (Edinburgh, Scotland)|June 27, 2025
Corrigendum to "Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022" [The Breast 78 (2024) 103790]A De Luca, M I Amabile, F Santori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytomaF Silvestri, G Barillari, R Fanin, et al.
Breast Cancer Research and Treatment|November 7, 2012
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozoleG Lunardi, P Piccioli, P Bruzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 16, 2023
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)P Di Nardo, D Basile, A Siciliano, et al.
European Review for Medical and Pharmacological Sciences|March 28, 2019
Biological properties of Cakile maritima Scop. (Brassicaceae) extractsV Fuochi, I Barbagallo, A Distefano, et al.
ESMO Open|January 7, 2026
Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trialsR Borea, E Blondeaux, L Carmisciano, et al.
Pageof 13